×
To start your customized experience click the start button
Customize ?  
Start
Cancer Types
Quick Links
Events
Award Programs
About Us
Careers
Contact Us
Newsroom
Privacy Policy
Terms & Conditions
 
Twitter
Face Book
YouTube
Instagram
 
 
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2019
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.

Metastatic Breast Cancer

Martha Carlson
Survival strategies for her best life help this metastatic cancer patient navigate a new world in the wake of the COVID-19 pandemic. 
Ryan McDonald
The Food and Drug Administration approved an updated dose of Ontruzant, a biosimilar to Herceptin, for multiple cancer types.
Stephanie Seban
Understanding a diagnosis is not just something for a patient's care team, the patient needs to understand their diagnosis as well.   
Stephanie Seban
Don’t be worried to get a second opinion — it could save your life.
 
Conor Killmurray
The COVID-19 pandemic has reached across the globe and continues to change, rapidly impacting everyone. Here are some of the stories around the world highlighting how the pandemic has impacted the lives of patients with cancer.
 
Ryan McDonald
The combination of Kisqali and Faslodex shows improved overall survival in patients with hormone-receptor-positive, HER2-negative advanced breast cancer.
Nancy Lin, M.D.
A recent study looking at data from three clinical trials involving Nerlynx shows promise for the future of treating patients with HER-2 positive breast cancer who develop CNS metastases.
Mary E. Burman
×
×

Sign In

Not a member? Sign up now!
Continue without login
Continue
×